In a report published Tuesday, Stifel Nicolaus analyst Michael Baudendistel downgraded the rating on GATX (NYSE: GMT) from Buy to Hold, and removed the $55.00 price target.

In a report published Tuesday, Goldman Sachs analyst Robert P. Jones downgraded the rating on Charles River Laboratories (NYSE: CRL) from Neutral to Sell, and lowered the price target from $44.00 to $38.00.

In a report published Tuesday, Bank of America analyst Derik de Bruin downgraded the rating on Genomic Health (NASDAQ: GHDX) from Buy to Neutral, and lowered the price target from $43.00 to $36.00.

LONDON, June 18 (Reuters) - Ratings agency Moody's on Tuesday said it had downgraded the senior debt and deposit ratings of the UK's Co-operative Bank, a day after the bank announced a 1.5 billion...

Analysts shift stance on 3D Systems, ConocoPhillips, and Statoil.

The agency cited the threat that political instability and infighting posed to economic policy making as the principal reason for cutting its rating

NEW YORK, June 17 (Reuters) - Standard & Poor's downgraded Venezuela's sovereign foreign currency credit rating by one notch on Monday, citing political turmoil as an impediment to enacting...

NEW YORK, June 17 (Reuters) - Standard & Poor's on Monday downgraded the sovereign foreign currency credit rating for Venezuela to B from B-plus, citing political turmoil as an impediment to enacting...

NEW YORK, June 17 (Reuters) - Standard & Poor's on Monday downgraded the sovereign foreign currency credit rating for Venezuela to B from B-plus, citing political turmoil as an impediment to enacting meaningful reforms in order to stop a slide in eco

NEW YORK, June 17 (Reuters) - Standard & Poor's on Monday downgraded the sovereign foreign currency credit rating for Venezuela to B from B-plus, citing political turmoil as an impediment to enacting...

NEW YORK, June 17 (Reuters) - Standard & Poor's on Monday downgraded the sovereign foreign currency credit rating for Venezuela to B from B-plus.

NEW YORK, June 17 (Reuters) - Standard & Poor's on Monday downgraded the sovereign foreign currency credit rating for Venezuela to B from B-plus.

NEW YORK, June 17 (Reuters) - Standard & Poor's on Monday downgraded the sovereign foreign currency credit rating for Venezuela to B from B-plus.

In a report published Monday, Jefferies analyst George C. Notter downgraded the rating on Infinera (NASDAQ: INFN) from Buy to Hold, but raised the price target from $9.00 to $12.00.

Capital Mortgage S.r.l. (BIPCA Cordusio RMBS), Capital Mortgage S.r.l. (Capital Mortgages Series 2007-1), Eurohome (Italy) Mortgages S.r.l. and Eurohome Mortgages 2007-1 plc

In a report published Monday, LifeTech Capital analyst Stephen M. Dunn downgraded the rating on Echo Therapeutics (NASDAQ: ECTE) from Strong Speculative Buy to Neutral, and removed the $3.75 price target.

In a report published on Monday, Piper Jaffray analyst Michael J. Grondahl downgraded Encore Capital (NASDAQ: ECGP) from Overweight to Neutral and maintained a price target of $36 on the company.

Analysts at Jefferies downgraded Infinera (NASDAQ: INFN) from “buy” to “hold.” The target price for Infinera has been raised from $9 to $12. Infinera's shares closed at $11.24 on Friday.

Analysts fell under Samsung Electronics Co Ltd's marketing spell when they made what they now admit were hopelessly optimistic forecasts for its smartphone sales. Samsung's huge share of the high-end smartphone market also persuad

Listed Thai firms are at risk of earnings downgrades, thanks to the prospect of weaker growth in the domestic economy, two brokerages said during a seminar on Monday.

June 17 (Reuters) - (The following statement was released by the rating agency)

June 17 (Reuters) - (The following statement was released by the rating agency)

June 17 (Reuters) - (The following statement was released by the rating agency)

NEW YORK, June 14 (Reuters) - Standard & Poor's on Friday downgraded Aruba's sovereign credit rating one notch to BBB-plus from A-minus, citing deteriorating fiscal and external balance sheets...

NEW YORK, June 14 (Reuters) - Standard & Poor's on Friday downgraded Aruba's sovereign credit rating one notch to BBB-plus from A-minus, citing deteriorating fiscal and external balance sheets...

NEW YORK, June 14 (Reuters) - Standard & Poor's on Friday downgraded Aruba's sovereign credit rating one notch to BBB-plus from A-minus, citing deteriorating fiscal and external balance sheets following closure of the island's oil refinery.

NEW YORK, June 14 (Reuters) - Standard & Poor's on Friday downgraded Aruba's sovereign credit rating one notch to BBB-plus from A-minus.

NEW YORK, June 14 (Reuters) - Standard & Poor's on Friday downgraded Aruba's sovereign credit rating one notch to BBB-plus from A-minus.

NEW YORK, June 14 (Reuters) - Standard & Poor's on Friday downgraded Aruba's sovereign credit rating one notch to BBB-plus from A-minus.

June 14 (Reuters) - Fitch downgraded debt issued by Detroit on Friday after the city said it planned on skipping a payment on its pension debt to conserve cash.

In a report published Friday, Sterne Agee analyst Todd L. Hagerman downgraded the rating on Wells Fargo (NYSE: WFC) from Buy to Neutral, but reiterated the $42.00 price target.

Stifel analyst Selman Akyol downgraded Williams Partners (NYSE: WPZ) to Hold on the heels of an expected negative financial impact from Geismar olefins plant explosion on Thursday.Akyol said the explosion will significantly affect Williams Partners i

In a report published Friday, Jefferies analyst Paul B. Fremont downgraded the rating on The Southern Company (NYSE: SO) from Buy to Hold, and lowered the price target from $53.50 to $46.00.

In a report published Friday, Goldman Sachs analyst Brian Lee downgraded the rating on Rubicon Technology (NASDAQ: RBCN) from Neutral to Sell, but reiterated the $6.00 price target.

In a report published on Friday, Bank of America analyst Derik de Bruin downgraded its rating on Myriad Genetics (NASDAQ: MYGN) from Buy to Neutral. Bank of America also lowered its price target on the company from $37 to $35.

In a report published on Friday, Bank of America analyst Kevin W. McCarthy downgraded Dupont (NYSE: DD) from Buy to Neutral and maintained a $56 price target on the company.

For the full text of this story please click the following link:

Analysts at Sterne Agee downgraded Wells Fargo & Company (NYSE: WFC) from “buy” to “neutral.” The target price for Wells Fargo is set to $42. Wells Fargo's shares closed at $40.94 yesterday.

For the full text of this story please click the following link:

MIDF Research has downgraded Top Glove Corp Bhd, the world's largest rubber glove maker, to 'neutral' from 'buy' as it sees a limited upside following the strengthening of the company's shares recently.

In a report published on Thursday, Topeka Capital Markets analyst Chris Kapsch downgraded Polypore International (NYSE: PPO) from Buy to Hold and maintained a price target of $44.

In a report published Thursday, Goldman Sachs analyst Alex Ovshey downgraded the rating on Republic Services (NYSE: RSG) from Conviction List-Buy to Buy, but reiterated the $37.00 price target.

Analysts at Goldman Sachs downgraded Waste Management (NYSE: WM) from “buy” to “neutral.” The target price for Waste Management is set to $42. Waste Management's shares closed at $40.14 yesterday.

SAN JUAN, June 12 (Reuters) - Puerto Rico policymakers have agreed to hike taxes by $1.5 billion as part of a budget which is closely watched by U.S. credit-ratings agencies weighing downgrades of...

In a report published Wednesday, Credit Suisse analyst Gregory Lewis downgraded the rating on Ocean Rig (NASDAQ: ORIG) from Outperform to Neutral, and lowered the price target from $20.00 to $19.00.

Yesterday's biggest laggard tops the list yet again, downgrades and negative momentum hit the other two

In a report published Wednesday, Deutsche Bank analyst Mark Wilde downgraded the rating on KapStone and Packaging (NYSE: KS) from Buy to Hold, but raised the price target from $31.00 to $38.00.

In a report published on Tuesday, Bank of America analyst Gabe Moreen downgraded MPLX (NYSE: MPLX) from Buy to Neutral while raising the price objective on the company from $32 to $40.

Analysts at Citigroup downgraded Biogen Idec (NASDAQ: BIIB) from “buy” to “neutral.” The target price for Biogen Idec has been raised from $235 to $236. Biogen Idec's shares closed at $223.03 yesterday.

June 12 (Reuters) - (The following statement was released by the rating agency)